Navigation Links
MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
Date:1/23/2013

TUCSON, Ariz. (PRWEB) January 23, 2013

The Muscular Dystrophy Association (MDA) has launched a clinical research network that will provide an infrastructure for trials of new treatments for myotonic muscular dystrophy (MMD, also known as DM). The rapid pace of research in this disease was the impetus behind the development of the network.

Each center in the new network has a particular interest and expertise in MMD, and the centers are distributed across the United States to maximize opportunities for participation in studies. Neurologist Charles Thornton at the University of Rochester Medical Center is the overall principal investigator for the network.

There are five university-based centers with expertise in this disorder that make up the network. Their first task will be to determine the usual progression of myotonic dystrophy and the best ways to measure the response of the disease to experimental treatments now in the developmental pipeline.

The five centers are:

Stanford University School of Medicine, Stanford, Calif. | Director: John Day, M.D., Ph.D.

University of Florida College of Medicine, Gainesville, Fla. | Director: Tetsuo Ashizawa, M.D.

University of Kansas Medical Center Research Institute, Kansas City, Kan. | Director: Richard Barohn, M.D.

University of Rochester Medical Center, Rochester, N.Y. | Director: Charles Thornton, M.D.

Ohio State University Medical Center, Columbus, Ohio | Director: John Kissel, M.D.

Network a response to scientific progress

"Recent years have seen rapid progress in the development of molecularly targeted therapy for myotonic dystrophy," said Jane Larkindale, MDA's director of translational research. "Basic research has shown that this disorder involves a disease mechanism known as 'RNA toxicity,' and translational research has shown that this mechanism is unusually responsive to therapeutic intervention. Based on the current pace of therapeutic development, it is reasonable to expect that new therapies will be advanced into clinical trials in the near future, and the new network will ensure that we're prepared for that."

About myotonic muscular dystrophy

Myotonic muscular dystrophy (MMD) is a common form of muscular dystrophy that weakens skeletal muscles and also can affect many other organs in the body, including the heart, eyes, brain and gastrointestinal tract. Caused by an abnormal expansion of DNA on either chromosome 19 or chromosome 3, the disease also is known as "dystrophia myotonica," or "DM."

For more on MMD and current research, see:

About MDA
MDA is the nonprofit health agency dedicated to finding treatments and cures for muscular dystrophy, ALS and related diseases by funding worldwide research. The Association also provides comprehensive health care and support services, advocacy and education.

In addition to funding some 300 research projects worldwide, MDA maintains a national network of 200 medical clinics; facilitates hundreds of support groups for families affected by neuromuscular diseases; and provides local summer camp opportunities for thousands of youngsters living with progressive muscle diseases.

For more information, visit mda.org and follow MDA on Facebook (facebook.com/MDAnational) and Twitter (@MDAnews).

  • MDA-

Read the full story at http://www.prweb.com/releases/2013/1/prweb10351245.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. DuPont Pioneer Launches Next Generation T Series Soybeans
2. MedZilla.com Launches New Site Design for 2013, Slick New Interface Impresses
3. New EMR Comparison Website Launches Crowdsourcing Electronic Medical Record Software Reviews and Comparisons
4. ActiGraph Launches ActiLife Mobile App
5. Rockingham County Economic Development Launches New Website to Market Research and Tech Park
6. Scout Girl, LLC Launches Website Featuring Vermicomposting Supplies
7. Wysebridge Launches Patent Bar Exam Study Review
8. Junior Varsity Naturals launches sweepstakes with Sweepstakes Ninja
9. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
10. Graphic Design Company, Project6 Design, Launches New Brand And Responsive Website For Innovative Biotech Company PaxVax
11. Bayer CropScience Launches Third Annual Young Farmer Sustainability Award Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016 --> ... an innovation-driven oncology company developing next generation cancer ... today announced that chairman emeritus of Tata Sons ... the company as part of the first close ... investors Navam Capital and Aarin Capital. ...
(Date:2/8/2016)... 2016  BioElectronics Corporation (OTC Pink: BIEL), the ... that it is responding to a notice of ... and Exchange Commission posted on the agency website.  ... the Board of BioElectronics Corporation and the Edward ... The Fuqua School of Business, Duke University.   ...
(Date:2/8/2016)... ... 2016 , ... Franz Inc. , an early innovator ... announced the availability of AllegroGraph 6, the leading Semantic Graph Database with certification ... Program (CCPT). AllegroGraph is the first Semantic Graph Database to be certified ...
(Date:2/8/2016)... Mich. , Feb. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its ... a specialty pharmacy resource–user-centric, story-driven, knowledge-based and mobile-friendly. ... ... ... "The goal ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/13/2016)... January 13, 2016 --> ... a new market report titled - Biometric Sensors Market - ... 2015 - 2023. According to the report, the global biometric sensors ... anticipated to reach US$1,625.8 mn by 2023, expanding at ... terms of volume, the biometric sensors market is expected ...
(Date:1/8/2016)... ANGELES and MANCHESTER, United Kingdom ... ("BBI"), a developer of innovative sensor-based diagnostic products, today announced ... financed by new and existing investors.  Proceeds from the financing ... SEM Scanner , a hand-held device for detecting early-stage pressure ... Ireland after receiving CE Mark approval. ...
Breaking Biology News(10 mins):